Notably, mutations in the PIK3 CA gene, which encodes a subunit of phosphoinositide 3-kinase, have been identified in some SPNs, suggesting that alterations in the PI3 K-AKT signaling pathway may play a role in tumor development [25–28]. The gene discussed is AKT1; the disease is neoplasm.